DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
L-Lysine is an investigational drug.
There have been 13 clinical trials for L-Lysine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Syndrome, Leukemia, and Preleukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Roswell Park Cancer Institute, and Simbec Research.
There are two hundred and ten US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for L-Lysine
|Nab-Paclitaxel and Durvalumab With or Without Neoantigen Vaccine in Treating Patients With Metastatic Triple Negative Breast Cancer||National Cancer Institute (NCI)||Phase 2|
|DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia||National Cancer Institute (NCI)||Phase 1|
|DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia||Roswell Park Cancer Institute||Phase 1|
Top disease conditions for L-Lysine
Top clinical trial sponsors for L-Lysine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|L-Lysine||Start Trial||Acrylamidobenzoic acid derivatives and their use||Sawai Pharmaceutical Co., Ltd. (Osaka, JP)||Start Trial|
|L-Lysine||Start Trial||Novel peptidyl carbamate inhibitors of the enzyme elastase||University of Kentucky Research Foundation (Lexington, KY)||Start Trial|
|L-Lysine||Start Trial||Polymers of citric acid and diamines, a process for their preparation and their uses, in particular as carriers of drugs||Sanofi (Paris, FR)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|L-Lysine||European Patent Office||0153850||2004-02-29||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|